Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study (Q45153118)

10 December 2017

title

Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

10 December 2017

0 references

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

Michael Torbenson

1 reference

10 December 2017

Jacob Alexander

1 reference

10 December 2017

Tsung-Teh Wu

series ordinal

1 reference

10 December 2017

Matthew M Yeh

series ordinal

1 reference

10 December 2017

publication date

1 May 2013

1 reference

Journal of Gastroenterology and Hepatology

10 December 2017

published in

1 reference

10 December 2017

1 reference

10 December 2017

1 reference

10 December 2017

page(s)

848-854

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

10 December 2017

cites work

1 reference

21 January 2018

Global cancer statistics

1 reference

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

21 January 2018

1 reference

Obesity and diabetes as a risk factor for hepatocellular carcinoma

21 January 2018

1 reference

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

21 January 2018

1 reference

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

21 January 2018

1 reference

The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans

21 January 2018

1 reference

The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma.

21 January 2018

1 reference

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

21 January 2018

1 reference

Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study

21 January 2018

1 reference

Excess risk of primary liver cancer in patients with diabetes mellitus

21 January 2018

1 reference

Long-term outcome of chronic hepatitis C infection in a low-prevalence area.

21 January 2018

1 reference

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review

21 January 2018

1 reference

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

21 January 2018

1 reference

Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.

21 January 2018

1 reference

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C

21 January 2018

1 reference

Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis

21 January 2018

1 reference

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

21 January 2018

1 reference

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Epidemiology of non-alcoholic fatty liver disease.

21 January 2018

1 reference

Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil

21 January 2018

1 reference

Hepatocellular carcinoma: an epidemiologic view

21 January 2018

1 reference

Non-alcoholic steatohepatitis and cancer

21 January 2018

1 reference

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

21 January 2018

1 reference

Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.

21 January 2018

1 reference

Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review

21 January 2018

1 reference

Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis

21 January 2018

1 reference

Primary liver cancers with nonalcoholic steatohepatitis

21 January 2018

1 reference

Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort

21 January 2018

1 reference

Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer

21 January 2018

1 reference

Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2.

21 January 2018

1 reference

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.12116

1 reference

10 December 2017

1 reference